1. OC.13.6 LARGE SUPERFICIAL NEOPLASMS IN INFLAMMATORY BOWEL DISEASES: ENDOSCOPIC SUBMUCOSAL DISSECTION STRATEGY. (1st October 2020) Authors: Iacopini, F.; Rigato, P.; Pica, R.; Calabrese, E.; Montagnese, F.; Lucidi, C.; Antenucci, C.; Saito, Y.; Gotoda, T.; Costamagna, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.07.13 FOUR-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS. (24th February 2016) Authors: Cassieri, C.; Pica, R.; Avallone, E.V.; Brandimarte, G.; Zippi, M.; Crispino, P.; De Nitto, D.; Corrado, C.; Vernia, P.; Paoluzi, P.; Corazziari, E.S. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 2 Page Start: e162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.11.1: Azathioprine in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients: Efficacy and Safety in Five Years of Follow-Up. (15th March 2017) Authors: Cassieri, C.; Pica, R.; Avallone, E.; Brandimarte, G.; Zippi, M.; Crispino, P.; De Nitto, D.; Lecca, G.P.; Vernia, P.; Paoluzi, P.; Corazziari, E.S. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P335 Two-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients. (February 2014) Authors: Cassieri, C.; Pica, R.; Avallone, E.V.; Zippi, M.; Corrado, C.; Vernia, P.; Paoluzi, P.; Corazziari, E.S. Journal: Journal of Crohn's and colitis Issue: Volume 8(2014)Supplement 1 Page Start: S204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM "LONG VEDO" ITALIAN MULTICENTER STUDY. (March 2023) Authors: Mocci, G.; Maconi, G.; Cataletti, G.; Mantia, B.; Serio, M.; Scarcelli, A.; Onidi, F.M.; Pagnini, C.; Graziani, M.; Di Paolo, M.; Pranzo, G.; Luppino, I.; Paese, P.; Monterubbianesi, R.; Faggiani, R.; Ferronato, A.; Perini, B.; Savarino, E.; Binaghi, L.; Schiavoni, E. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗